Middle East And Africa Gene Synthesis Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 45.53 Million |
 Market Size (Forecast Year) |
USD 166.43 Million |
 CAGR |
% |
| Major Markets Players |
Middle East And Africa Gene Synthesis Market, By Component (Synthesizer, Consumables, and Software & Services), Gene Type (Standard Gene, Express Gene, Complex Gene and Others), Gene Synthesis Type (Gene Library Synthesis, and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutics Antibodies, and Others), Method (Solid Phase Synthesis, Chip-Based DNA Synthesis, and PCR-Based Enzyme Synthesis), End User (Academic & Research Institutes, Diagnostics Laboratories, Biotech & Pharmaceutical Companies, and Others), Distribution Channel (Direct Tender, Online Distribution, and Third Party Distributors), Industry Trends and Forecast to 2029.
Middle East and Africa Gene Synthesis Market Analysis and Insights
Gene synthesis is the process of creating artificial genes in a lab setting using synthetic biology. The generation of recombinant proteins is one of the numerous applications of recombinant DNA technology, where gene synthesis is emerging as a key instrument. The traditional methods of cloning and mutagenesis are quickly being replaced by de novo gene synthesis, which also enables the production of nucleic acids for which there is no template.
Middle East and Africa gene synthesis market are expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 17.4% in the forecast period of 2022 to 2029 and is expected to reach USD 166.43 million by 2029 from USD 45.53 million in 2021.
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
By Component (Synthesizer, Consumables, and Software & Services), Gene Type (Standard Gene, Express Gene, Complex Gene and Others), Gene Synthesis Type (Gene Library Synthesis, and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutics Antibodies, and Others), Method (Solid Phase Synthesis, Chip-Based DNA Synthesis, and PCR-Based Enzyme Synthesis), End User (Academic & Research Institutes, Diagnostics Laboratories, Biotech & Pharmaceutical Companies, and Others), Distribution Channel (Direct Tender, Online Distribution, and Third Party Distributors) |
|
Countries Covered |
South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East, and Africa. |
|
Market Players Covered |
Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG: biosynthetic GmbH, Merck KGaA, Ginkgo Bioworks, Evonetix, ProMab Biotechnologies, Inc., CSBio, and Azenta US, Inc., among others. |
Market Definition
Gene synthesis refers to the chemical synthesis of DNA strand base-by base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for the creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
Gene Synthesis Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES
Bacterial and viral diseases are rapidly expanding due to the rising prevalence of infectious diseases worldwide. As a result, the demand for novel and effective therapies has increased to fight against such deadly diseases. These diseases can be cured by using chemical drugs and biological therapies, including gene therapy. By applying genomics, the management of infectious and endemic diseases has been enhanced. It also allows us to understand emerging drug resistance and identify targets for new therapeutics and vaccines. For the treatment of infectious diseases, gene therapy has attracted many researchers as it can be treated by using recombinant DNA technology, DNA &RNA ribozyme, and single chain antibodies.
As the rising prevalence of the chronic infectious disease is increasing globally, the demand for vaccines and effective gene therapy has also risen, which has increased the demand for novel genes with a significant application for research activities and drug and vaccine manufacturing. Thus, the rising prevalence of infectious diseases is acting as the driver for the gene synthesis market growth.
- RISING ADOPTION OF GENE THERAPY
Gene therapy is an advanced technique that includes the usage of several genes for the prevention of a particular disease type. The technique involves the insertion of genes into patient cells instead of drugs and surgery. Due to increased demand for novel and long-lasting therapy results, the adoption of gene therapy is rising. Gene therapies demand synthetic gene constructs, among other gene products, to accelerate gene therapy development. Due to the rise in genetic diseases, the demand for a proper cure is one major factor, and with the help of gene therapy, a particular disease type can be cured.
Due to the increased demand, leaders are constantly focused on producing gene therapy products, achieving approval, and marketing authorizations.
Lifesaving medicines and therapies are in huge demand to provide quality life to different kinds of patients. These rising numbers of patients are largely dependent upon the gene therapies available to achieve a proper cure. To manufacture gene therapies, synthetic and novel genes are required, which can be achieved by the gene synthesis technique. Thus, the rising adoption of gene therapy is expected to act as a driver for the gene synthesis market.
- EXPANSION OF SYNTHETIC BIOLOGY
The incorporation of engineering principles into biology is termed synthetic biology. DNA genome can be reassembled with the help of synthetic biology as it involves the chemical synthesis of DNA by combining it with its genome. Oligonucleotides can be constructed in a short period by incorporating the usage of gene synthesis services, software, and consumables. As synthetic biology products' demand increases worldwide, gene synthesis products and services are also increasing.
Thus, due to its effective and innovative products, the demand for synthetic biology products is increasing globally, which is expected to act as a driving factor for the gene synthesis market.
Opportunities
-
RISING HEALTHCARE EXPENDITURE
Healthcare expenditure has increased worldwide as people's disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure.
Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the medical device testing market in the forecast period of 2022-2029.
Restraints/Challenges
HIGH COST OF THE GENE SYNTHESIS PROCESS
However, the barriers to the gene synthesis techniques and the high cost of the gene synthesis process in some regions may impede the less growth of the gene synthesis procedures hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be challenging factors for the growth of the market
This gene synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you to make an informed market decision to achieve market growth.
Recent Development
- In December 2020, Twist Bioscience launched clonal-ready gene fragments to complete the offering of genes. The fragments launched can be used with adapters or without adapters to build up the perfect clones. The clonal-ready gene fragments are compatible with the protein expression pathways, enzyme engineering, and gene expression, among others.
- In 2020, according to an article published in an ACS journal, a total estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths were reported worldwide. This suggests that cancer coverage is suboptimal, and there is a great need to implement high cancer coverage all over the world.
Middle East and Africa Gene Synthesis Market Scope
The Middle East and Africa gene synthesis market are segmented into component, gene type, gene synthesis type, application, method, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Component
- Synthesizers
- Consumables
- Software & services
On the basis of component, the Middle East and Africa gene synthesis market is segmented into synthesizers, consumables, and software & services.
Gene Type
- Standard gene
- Express gene
- Complex gene
- Others
On the basis of gene type, the Middle East and Africa gene synthesis market is segmented into the standard gene, express gene, complex gene and others.
Gene Synthesis Type
- Gene library synthesis
- Custom gene synthesis
On the basis of gene synthesis type, the Middle East and Africa gene synthesis market is segmented into gene library synthesis and custom gene synthesis.
Application
- Synthetic biology,
- Genetic engineering,
- Vaccine design,
- Therapeutics antibodies
- Others
On the basis of application, the Middle East and Africa gene synthesis market is segmented into synthetic biology, genetic engineering, vaccine design, therapeutics antibodies, and others.
Method
- Solid based synthesis,
- Chip-based DNA synthesis
- PCR-based enzyme synthesis
On the basis of the method, the Middle East and Africa gene synthesis market is segmented into solid based synthesis, chip-based DNA synthesis, and PCR-based enzyme synthesis.
End User
- Academic & research institutes,
- Diagnostics laboratories,
- Biotech & pharmaceutical companies
- Others
On the basis of end users, the Middle East and Africa gene synthesis market is segmented into academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies, and others.
Distribution Channel
- Direct tender
- Online distribution
- Third party distributors
On the basis of distribution channels, the Middle East and Africa gene synthesis market is segmented into direct tender, online distribution, and third party distributors.
Gene Synthesis Market Regional Analysis/Insights
The gene synthesis market is analyzed, and market size insights and trends are provided by the country, component, gene type, gene synthesis type, application, method, end user, and distribution channel, as referenced above.
Saudi Arabia dominates the gene synthesis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising need for the verification and validation of gene synthesis processes in the region, and rapid research development is boosting the market
The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Gene Synthesis Market Share Analysis
The gene synthesis market competitive landscape provides details by the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies focus on the gene synthesis market.
Some of the major players operating in the gene synthesis market are ATDBio Ltd (Subsidiary of Biotage), General Biosystems, Inc., MACROGEN CO., LTD., Boster Biological Technology, Creative Biogene, Bioneer Pacific, exonbio, trenzyme GmbH, Twist Bioscience, BioCat GmbH (Subsidiary of AddLife AB), OriGene Technologies, Inc., Integrated DNA Technologies, Inc. 9Subsidiary of Danaher Corporation), Eurofins Scientific, NZYTech, Lda. - Genes and Enzymes, Ansa Biotechnologies, Inc., Thermo Fisher Scientific, Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG:biosynthetics GmbH, Merck KGaA, Kaneka Eurogentec S.A, Ginkgo Bioworks, Bbi-lifesciences, Evonetix, ProMab Biotechnologies, Inc., GCC Biotech (INDIA) Pvt. Ltd., CSBio, Azenta US, Inc., and among others.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Middle East and Africa vs. Regional and Vendor Share Analysis. Please request an analyst call in case of further inquiry.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 COMPONENT SEGMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 THE CATEGORY VS TIME GRID
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES
6.1.2 RISING ADOPTION OF GENE THERAPY
6.1.3 EXPANSION OF SYNTHETIC BIOLOGY
6.1.4 RISING INTEREST OF GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY
6.2 RESTRAINTS
6.2.1 LACK OF TRAINED PROFESSIONALS
6.2.2 ETHICAL ISSUES
6.2.3 LONG APPROVAL PROCESS
6.3 OPPORTUNITIES
6.3.1 RISE IN HEALTHCARE EXPENDITURE
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS
6.3.3 RISING DEMAND FOR CUSTOMIZED MEDICATIONS
6.4 CHALLENGES
6.4.1 TECHNICAL LIMITATIONS ACROSS PRODUCTION PROCESS
6.4.2 LACK OF WELL DEFINED PATENT SYSTEM
7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SOFTWARE & SERVICES
7.3 CONSUMABLES
7.3.1 REAGENTS
7.3.2 ASSAYS
7.3.3 PROBES & DYES
7.3.4 OTHERS
7.4 SYNTHESIZER
7.4.1 COLUMN-BASED SYNTHESIZERS
7.4.2 MICROARRAY-BASED SYNTHESIZERS
8 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE
8.1 OVERVIEW
8.2 STANDARD GENE
8.3 COMPLEX GENE
8.4 EXPRESS GENE
8.5 OTHERS
9 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE
9.1 OVERVIEW
9.2 CUSTOM GENE SYNTHESIS
9.2.1 STANDARD GENE
9.2.2 COMPLEX GENE
9.2.3 EXPRESS GENE
9.2.4 OTHERS
9.3 GENE LIBRARY SYNTHESIS
9.3.1 STANDARD GENE
9.3.2 COMPLEX GENE
9.3.3 EXPRESS GENE
9.3.4 OTHERS
10 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 SYNTHETIC BIOLOGY
10.2.1 CUSTOM GENE SYNTHESIS
10.2.2 GENE LIBRARY SYNTHESIS
10.3 GENETIC ENGINEERING
10.3.1 CUSTOM GENE SYNTHESIS
10.3.2 GENE LIBRARY SYNTHESIS
10.4 THERAPEUTIC ANTIBODIES
10.4.1 CUSTOM GENE SYNTHESIS
10.4.2 GENE LIBRARY SYNTHESIS
10.5 VACCINE DESIGN
10.5.1 CUSTOM GENE SYNTHESIS
10.5.2 GENE LIBRARY SYNTHESIS
10.6 OTHERS
11 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD
11.1 OVERVIEW
11.2 PCR-BASED ENZYME SYNTHESIS
11.3 CHIP-BASED DNA SYNTHESIS
11.4 SOLID BASED SYNTHESIS
12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER
12.1 OVERVIEW
12.2 ACADEMIC & RESEARCH INSTITUTE
12.3 BIOTECH & PHARMACEUTICAL COMPANIES
12.4 DIAGNOSTIC LABORATORIES
12.5 OTHERS
13 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 ONLINE DISTRIBUTION
13.4 THIRD PARTY DISTRIBUTORS
14 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY REGION
14.1 MIDDLE EAST &AFRICA
14.1.1 SAUDI ARABIA
14.1.2 SOUTH AFRICA
14.1.3 U.A.E.
14.1.4 ISRAEL
14.1.5 EGYPT
14.1.6 REST OF MIDDLE EAST & AFRICA
15 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER)
17.1.1 COMPANY SNAPSHOT
17.1.2 COMPANY SHARE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 THERMO FISHER SCIENTIFIC INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 EUROFINS SCIENTIFIC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 SERVICE PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 MERCK KGAA
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 KANEKA EUROGENTEC S.A.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 ANSA BIOTECHNOLOGIES, INC
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 ATD BIO LTD
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 ATG:BIOSYNTHETICS GMBH
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 AZENTUS US, INC (2021)
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 BBI LIFESCIENCES CORPORATION
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 BIO BASIC INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 BIOCAT GMBH
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 BIONEER PACIFIC
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 BOSTER BIOLOGICAL TECHNOLOGY
17.14.1 COMPANY SNAPSHOT
17.14.2 SERVICE PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 CSBIO
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 CREATIVE BIOGENE
17.16.1 COMPANY SNAPSHOT
17.16.2 RODUCTPORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 EVONETIX
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 EXONBIO
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 GCC BIOTECH (INDIA) PVT. LTD.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 GINKGO BIOWORKS (2021)
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 GENERAL BIOSYSTEMS INC
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 GENSCRIPT
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 MACROGEN CO., LTD. (A SUBSIDIARY OF MACROGEN, INC)
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 NZYTECH, LDA. - GENES AND ENZYMES.
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 ORIGENE TECHNOLOGIES, INC
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENTS
17.26 PROMAB BIOTECHNOLOGIES
17.26.1 COMPANY SNAPSHOT
17.26.2 PRODUCT PORTFOLIO
17.26.3 RECENT DEVELOPMENTS
17.27 PROTEOGENIX
17.27.1 COMPANY SNAPSHOT
17.27.2 PRODUCT PORTFOLIO
17.27.3 RECENT DEVELOPMENTS
17.28 SYNBIO TECHNOLOGIES
17.28.1 COMPANY SNAPSHOT
17.28.2 PRODUCT PORTFOLIO
17.28.3 RECENT DEVELOPMENTS
17.29 TRENZYME GMBH
17.29.1 COMPANY SNAPSHOT
17.29.2 PRODUCT PORTFOLIO
17.29.3 RECENT DEVELOPMENTS
17.3 TWIST BIOSCIENCE
17.30.1 COMPANY SNAPSHOT
17.30.2 REVENUE ANALYSIS
17.30.3 PRODUCT PORTFOLIO
17.30.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA STANDARD GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA COMPLEX GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA EXPRESS GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA PCR-BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA CHIP-BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA SOLID BASED SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA ACADEMIC & RESEARCH INSTITUTES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 56 SAUDI ARABIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 57 SAUDI ARABIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 SAUDI ARABIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 59 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 60 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 61 SAUDI ARABIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 62 SAUDI ARABIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 63 SAUDI ARABIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 SAUDI ARABIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 65 SAUDI ARABIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 66 SAUDI ARABIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 67 SAUDI ARABIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 68 SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 69 SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 SAUDI ARABIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 71 SOUTH AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 72 SOUTH AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 73 SOUTH AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 74 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 75 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 76 SOUTH AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 77 SOUTH AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 78 SOUTH AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 79 SOUTH AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 80 SOUTH AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 81 SOUTH AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 82 SOUTH AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 83 SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 84 SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 85 SOUTH AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 86 U.A.E GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 87 U.A.E CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 88 U.A.E SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 89 U.A.E GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 90 U.A.E GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 91 U.A.E CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 92 U.A.E GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 93 U.A.E GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 94 U.A.E SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 95 U.A.E GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 96 U.A.E THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 97 U.A.E VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 98 U.A.E GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 99 U.A.E GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 100 U.A.E GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 101 ISRAEL GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 102 ISRAEL CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 ISRAEL SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 ISRAEL GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 105 ISRAEL GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 106 ISRAEL CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 107 ISRAEL GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 108 ISRAEL GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 ISRAEL SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 110 ISRAEL GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 111 ISRAEL THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 112 ISRAEL VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 113 ISRAEL GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 114 ISRAEL GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 115 ISRAEL GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 116 EGYPT GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 117 EGYPT CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 118 EGYPT SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 119 EGYPT GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 120 EGYPT GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 121 EGYPT CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 122 EGYPT GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 123 EGYPT GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 124 EGYPT SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 125 EGYPT GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 126 EGYPT THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 127 EGYPT VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 128 EGYPT GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 129 EGYPT GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 130 EGYPT GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 131 REST OF MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: GEOGRAPHIC SCOPE
FIGURE 3 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DATA TRIANGULATION
FIGURE 4 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT
FIGURE 5 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BOTTOM UP APPROACH
FIGURE 6 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: TOP DOWN APPROACH
FIGURE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: THE CATEGORY VS TIME GRID
FIGURE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SEGMENTATION
FIGURE 13 GROWING PREVALENCE OF CHRONIC INFECTIOUS DISEASES , EXPANSION OF SYNTHETIC BIOLOGY AND RISING ADOPTION OF GENE THERAPY ARE EXPECTED TO DRIVE THE MARKET FOR MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 SYNTHESIZER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN 2022 & 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET
FIGURE 16 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2021
FIGURE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2022-2029 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, CAGR (2022-2029)
FIGURE 19 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2021
FIGURE 21 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2022-2029 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2022-2029)
FIGURE 23 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2021
FIGURE 25 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2022-2029 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, CAGR (2022-2029)
FIGURE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2021
FIGURE 29 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 30 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2021
FIGURE 33 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2022-2029 (USD MILLION)
FIGURE 34 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 35 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE
FIGURE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021
FIGURE 37 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021-2029 (USD MILLION)
FIGURE 38 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 39 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 42 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 43 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT (2021)
FIGURE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021)
FIGURE 46 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 47 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029)
FIGURE 49 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
